AVR 1.05% $18.90 anteris technologies ltd

Upcoming Quarterly, page-39

  1. 927 Posts.
    lightbulb Created with Sketch. 16
    No, numbers reported are for sales, no trials/pro bono numbers are included in reports.

    The whole point of course is that the unfortunate increased incidence of rheumatic fever in Aboriginal children gives an increased no. of mitral valve paediatric patients needing surgical repair.

    Rheumatic fever is an "old disease" that no longer occurs in great numbers in the developed world due to better hygiene and antibiotics, however this cohort of patients will mean an accelerated view into what CC can do for
    a) Mitral valve repairs and
    b) Paediatric patients.

    So everyone will eventually benefit from this most unfortunate situation. The patients will get better surgical protheses with the prospect at this stage from all available evidence that revisions will not be necessary, and the coy will generate data at a faster rate for valve repairs and the paediatric population.
    Last edited by Risiko: 18/04/15
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$18.90
Change
-0.200(1.05%)
Mkt cap ! $363.3M
Open High Low Value Volume
$18.98 $19.20 $18.70 $167.6K 8.851K

Buyers (Bids)

No. Vol. Price($)
1 49 $18.90
 

Sellers (Offers)

Price($) Vol. No.
$18.95 100 1
View Market Depth
Last trade - 16.10pm 06/06/2024 (20 minute delay) ?
Last
$18.90
  Change
-0.200 ( 0.42 %)
Open High Low Volume
$18.95 $18.95 $18.59 213
Last updated 15.51pm 06/06/2024 ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.